{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:09:59Z","timestamp":1793293799723,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Eye Institute, the National Institutes of Health","award":["U10 EY08052"],"award-info":[{"award-number":["U10 EY08052"]}]},{"name":"Johns Hopkins University School of Medicine","award":["RO1 EY10268"],"award-info":[{"award-number":["RO1 EY10268"]}]},{"name":"Johns Hopkins University School of Medicine","award":["R03 EY015643"],"award-info":[{"award-number":["R03 EY015643"]}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ajo.2010.10.018","type":"journal-article","created":{"date-parts":[[2010,12,19]],"date-time":"2010-12-19T04:06:15Z","timestamp":1292731575000},"page":"198-216.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Cytomegalovirus Retinitis and the Acquired Immunodeficiency Syndrome\u2014Bench to Bedside: LXVII Edward Jackson Memorial Lecture"],"prefix":"10.1016","volume":"151","author":[{"given":"Douglas A.","family":"Jabs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9394(77)90454-8","article-title":"Cytomegalovirus retinitis secondary to chronic viremia in phagocytic leukocytes","volume":"84","author":"Fiala","year":"1977","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/infdis\/132.4.421","article-title":"Epidemiology of cytomegalovirus infection after transplantation and immunosuppression","volume":"132","author":"Fiala","year":"1975","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib3","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/archopht.1994.01090150102031","article-title":"The eye in bone marrow transplantation: VI. Retinal complications","volume":"112","author":"Coskuncan","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajo.2004.04.015","article-title":"Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection","volume":"138","author":"Kuo","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2010.10.018_bib5","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"10.1016\/j.ajo.2010.10.018_bib6","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","article-title":"Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine","volume":"166","author":"Gallant","year":"1992","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.ajo.2010.10.018_bib7","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.ajo.2010.10.018_bib8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1086\/517303","article-title":"T cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients","volume":"176","author":"Tay-Kearney","year":"1997","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajo.2007.09.023","article-title":"Characteristics of untreated AIDS-related cytomegalovirus retinitis","volume":"145","author":"Holland","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2010.10.018_bib11","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/clinids\/20.5.1250","article-title":"An epidemiologic analysis of Mycobacterium avium complex disease in homosexual men infected with human immunodeficiency virus type 1","volume":"20","author":"Hoover","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"13","key":"10.1016\/j.ajo.2010.10.018_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ajo.2010.10.018_bib13","first-page":"1931","article-title":"Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997","volume":"12","author":"Holtzer","year":"1998","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/313612","article-title":"Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy","volume":"30","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ophtha.2006.11.008","article-title":"Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment 1","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2010.10.018_bib16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archopht.126.8.1143","article-title":"AIDS and ophthalmology, 2008","volume":"126","author":"Jabs","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-148-3-200802050-00004","article-title":"Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model","volume":"148","author":"Braithwaite","year":"2008","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.ajo.2010.10.018_bib18","first-page":"661","article-title":"Late HIV testing - 34 states, 1996-2005","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajo.2010.10.018_bib19","series-title":"AIDS Therapy","first-page":"855","article-title":"Cytomegalovirus disease","author":"Griffiths","year":"2008"},{"issue":"5","key":"10.1016\/j.ajo.2010.10.018_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/oxfordjournals.aje.a121347","article-title":"Seroepidemiology of infections due to members of the herpesvirus group","volume":"94","author":"Wentworth","year":"1971","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.ajo.2010.10.018_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/infdis\/143.2.188","article-title":"Prevalence of cytomegalovirus infection in homosexual men","volume":"143","author":"Drew","year":"1981","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9394(98)00134-2","article-title":"Cytomegalovirus retinitis and viral resistance: 3. Culture results","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/432012","article-title":"Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis","volume":"192","author":"Jabs","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajo.2010.10.018_bib24","first-page":"111","article-title":"Role of retinal vascular endothelial cells in development of CMV retinitis","volume":"96","author":"Rao","year":"1998","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0161-6420(85)34008-3","article-title":"Acquired immune deficiency syndrome","volume":"92","author":"Pepose","year":"1985","journal-title":"Ophthalmology"},{"issue":"23","key":"10.1016\/j.ajo.2010.10.018_bib26","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1073\/pnas.84.23.8642","article-title":"Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus","volume":"84","author":"Davis","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/infdis\/157.3.508","article-title":"Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus","volume":"157","author":"Skolnik","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajo.2010.10.018_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0002-9394(89)90659-4","article-title":"Dual infection of retina with human immunodeficiency virus type 1 and cytomegalovirus","volume":"107","author":"Skolnik","year":"1989","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib29","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1073\/pnas.97.4.1695","article-title":"Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)","volume":"97","author":"Kotenko","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib30","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/JVI.76.3.1285-1292.2002","article-title":"Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10","volume":"76","author":"Spencer","year":"2002","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.ajo.2010.10.018_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-2427(98)00090-7","article-title":"Pathogen interactions with cytokines and host defence: an overview","volume":"63","author":"Seow","year":"1998","journal-title":"Vet Immunol Immunopathol"},{"issue":"5\u20136","key":"10.1016\/j.ajo.2010.10.018_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000053970","article-title":"Molecular mimicry by cytomegaloviruses","volume":"42","author":"Vink","year":"1999","journal-title":"Intervirology"},{"issue":"2","key":"10.1016\/j.ajo.2010.10.018_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199907083410203","article-title":"Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women","volume":"341","author":"Kovacs","year":"1999","journal-title":"N Engl J Med"},{"issue":"8654","key":"10.1016\/j.ajo.2010.10.018_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(89)90312-7","article-title":"Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection","volume":"2","author":"Webster","year":"1989","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ajo.2010.10.018_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S095026880005799X","article-title":"The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion","volume":"114","author":"Sabin","year":"1995","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.ajo.2010.10.018_bib36","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0161-6420(94)31181-X","article-title":"Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial","volume":"101","year":"1994","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archopht.1996.01100130021004","article-title":"Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2010.10.018_bib38","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/archopht.1997.01100160698006","article-title":"MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trial","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archopht.121.1.99","article-title":"Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy","volume":"121","author":"Holbrook","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2010.10.018_bib40","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ophtha.2006.03.021","article-title":"Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"113","author":"Thorne","year":"2006","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2010.10.018_bib41","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ophtha.2006.03.022","article-title":"Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"113","author":"Thorne","year":"2006","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.ajo.2010.10.018_bib43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0898-953","article-title":"Restoration of cytomegalovirus specific CD4+ T lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1","volume":"4","author":"Komanduri","year":"1998","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ajo.2010.10.018_bib44","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/319219","article-title":"Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution","volume":"32","author":"Johnson","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ajo.2010.10.018_bib45","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/319683","article-title":"Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis","volume":"183","author":"Komanduri","year":"2001","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ajo.2010.10.018_bib46","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9394(98)00285-2","article-title":"Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2010.10.018_bib47","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1086\/515281","article-title":"Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy","volume":"177","author":"Macdonald","year":"1998","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.ajo.2010.10.018_bib48","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.282.17.1633","article-title":"Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis","volume":"282","author":"Whitcup","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib49","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-137-4-200208200-00008","article-title":"Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy","volume":"137","author":"Kirk","year":"2002","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ajo.2010.10.018_bib50","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002030-200001280-00013","article-title":"CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy","volume":"14","author":"Torriani","year":"2000","journal-title":"AIDS"},{"issue":"RR-4","key":"10.1016\/j.ajo.2010.10.018_bib51","first-page":"55","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.ajo.2010.10.018_bib52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9394(14)70778-0","article-title":"Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis","volume":"124","year":"1997","journal-title":"Am J Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib53","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ophtha.2006.07.065","article-title":"Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2010.10.018_bib54","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9394(00)00356-1","article-title":"Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy","volume":"129","author":"Nguyen","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9394(00)00530-4","article-title":"Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy","volume":"130","author":"Robinson","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib56","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1086\/314639","article-title":"Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy","volume":"179","author":"Karavellas","year":"1999","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib57","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ophtha.2005.10.067","article-title":"Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis","volume":"113","author":"Kempen","year":"2006","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2010.10.018_bib58","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0161-6420(97)30188-2","article-title":"Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome","volume":"104","author":"Taskintuna","year":"1997","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib59","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0002-9394(99)80149-4","article-title":"Human immunodeficiency virus disease: changing patterns of intraocular inflammation","volume":"125","author":"Nussenblatt","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2010.10.018_bib60","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ophtha.2010.03.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: Five-year outcomes","volume":"117","author":"Jabs","year":"2010","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2010.10.018_bib61","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/01.aids.0000166100.36638.97","article-title":"Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy","volume":"19","author":"Ortega-Larrocea","year":"2005","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.ajo.2010.10.018_bib62","doi-asserted-by":"crossref","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","article-title":"Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial","volume":"4","author":"Zolopa","year":"2009","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ajo.2010.10.018_bib63","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/0003-4819-115-9-665","article-title":"A randomized, controlled trial of Foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS","volume":"115","author":"Palestine","year":"1991","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib64","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/168.3.557","article-title":"A randomized controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS","volume":"168","author":"Spector","year":"1993","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJM199201233260401","article-title":"Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis","volume":"326","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib66","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-126-4-199702150-00002","article-title":"Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC Peripheral Cytomegalovirus Retinitis Trial","volume":"126","year":"1997","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-126-4-199702150-00001","article-title":"Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: A randomized, controlled trial","volume":"126","author":"Lalezari","year":"1997","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ajo.2010.10.018_bib68","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.1994.01090240037023","article-title":"Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant","volume":"112","author":"Martin","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2010.10.018_bib69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199707103370203","article-title":"Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant","volume":"337","author":"Musch","year":"1997","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ajo.2010.10.018_bib70","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9394(01)00840-6","article-title":"The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial","volume":"131","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"15","key":"10.1016\/j.ajo.2010.10.018_bib72","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa011759","article-title":"A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis","volume":"346","author":"Martin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2010.10.018_bib73","unstructured":"Jabs DA. Clinical research in uveitis. In: Zierhut M, editor. Uveitis. New York: Springer Publishing Company. Forthcoming."},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib74","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0197-2456(92)90027-W","article-title":"1. Rationale, design, and methods","volume":"13","year":"1992","journal-title":"Control Clin Trials"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib75","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archopht.119.4.554","article-title":"Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients","volume":"119","author":"Holbrook","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib76","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ajo.2003.10.002","article-title":"Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression","volume":"137","author":"Hubbard","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2010.10.018_bib77","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archopht.1989.01070020841024","article-title":"A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standardized system for the assessment of disease outcome","volume":"107","author":"Holland","year":"1989","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2010.10.018_bib78","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/00002030-200007280-00013","article-title":"Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial","volume":"14","year":"2000","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.ajo.2010.10.018_bib79","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/archopht.1997.01100160559005","article-title":"Ganciclovir implant exchange: timing, surgical procedure, and complications","volume":"115","author":"Martin","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2010.10.018_bib80","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1086\/379077","article-title":"Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome","volume":"37","author":"Kempen","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ajo.2010.10.018_bib81","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/bjo.78.2.120","article-title":"High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS","volume":"78","author":"Diaz-Llopis","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2010.10.018_bib82","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0161-6420(98)98020-4","article-title":"High-dose (2000-\u03bcg) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis","volume":"105","author":"Young","year":"1998","journal-title":"Ophthalmology"},{"issue":"47","key":"10.1016\/j.ajo.2010.10.018_bib83","first-page":"38","article-title":"Managing CMV retinitis in the developing world","volume":"16","author":"Visser","year":"2003","journal-title":"Community Eye Health"},{"issue":"12","key":"10.1016\/j.ajo.2010.10.018_bib84","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ophtha.2004.05.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. retinitis progresion","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2010.10.018_bib85","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2004.05.028","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. second eye involvement and retinal detachment","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib86","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9394(14)71645-9","article-title":"Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial","volume":"124","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib87","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jmv.1890250311","article-title":"Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis","volume":"25","author":"Jacobson","year":"1988","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.ajo.2010.10.018_bib88","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/infdis\/168.6.1506","article-title":"Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy","volume":"168","author":"Kuppermann","year":"1993","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib89","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/infdis\/172.4.951","article-title":"Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis","volume":"172","author":"Arevalo","year":"1995","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.ajo.2010.10.018_bib90","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archopht.1996.01100140023002","article-title":"Cytomegalovirus retinitis and viral resistance: prevalence of resistance at diagnosis, 1994","volume":"114","author":"Jabs","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib91","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/infdis\/163.4.716","article-title":"Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection","volume":"163","author":"Drew","year":"1991","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib92","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/514249","article-title":"Cytomegalovirus retinitis and viral resistance: ganciclovir resistance","volume":"177","author":"Jabs","year":"1998","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.ajo.2010.10.018_bib93","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.42.9.2240","article-title":"Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis","volume":"42","author":"Jabs","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ajo.2010.10.018_bib94","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1086\/368385","article-title":"Mutations conferring foscarnet resistance in a cohort of patients with the acquired immunodeficiency syndrome and cytomegalovirus retinitis","volume":"187","author":"Weinberg","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ajo.2010.10.018_bib95","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/317931","article-title":"Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis","volume":"183","author":"Jabs","year":"2001","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ajo.2010.10.018_bib96","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0002-9394(01)01161-8","article-title":"Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8","volume":"132","author":"Jabs","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib97","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1086\/517302","article-title":"Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease","volume":"176","author":"Chou","year":"1997","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ajo.2010.10.018_bib98","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1086\/516446","article-title":"Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients","volume":"175","author":"Erice","year":"1997","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ajo.2010.10.018_bib99","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.43.6.1500","article-title":"Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance","volume":"43","author":"Chou","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ajo.2010.10.018_bib100","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1128\/AAC.45.10.2775-2780.2001","article-title":"Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing","volume":"45","author":"Lurain","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ajo.2010.10.018_bib101","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/338362","article-title":"Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir","volume":"185","author":"Chou","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ajo.2010.10.018_bib102","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/CMR.12.2.286","article-title":"Resistance of human cytomegalovirus to antiviral drugs","volume":"12","author":"Erice","year":"1999","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib103","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/375743","article-title":"Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus","volume":"188","author":"Chou","year":"2003","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1086\/514041","article-title":"High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes","volume":"176","author":"Smith","year":"1997","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.ajo.2010.10.018_bib105","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1093\/clinids\/21.Supplement_2.S170","article-title":"Molecular detection of human cytomegalovirus and determination of genotypic ganciclovir resistance in clinical specimens","volume":"21","author":"Spector","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib106","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/jcm.33.3.738-741.1995","article-title":"Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples","volume":"33","author":"Gerna","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.ajo.2010.10.018_bib107","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0002-9394(14)70217-X","article-title":"Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir","volume":"119","author":"Dunn","year":"1995","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib108","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/09286589709058060","article-title":"Viral resistance and CMV retinitis: design and methods of a prospective study","volume":"4","author":"Enger","year":"1997","journal-title":"Ophthalmic Epidemiol"},{"issue":"7","key":"10.1016\/j.ajo.2010.10.018_bib109","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/339603","article-title":"Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis","volume":"185","author":"Hu","year":"2002","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(02)01759-2","article-title":"Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis","volume":"135","author":"Jabs","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2010.10.018_bib111","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1086\/504270","article-title":"Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome","volume":"193","author":"Jabs","year":"2006","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.ajo.2010.10.018_bib112","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/512368","article-title":"Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis","volume":"44","author":"Martin","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ajo.2010.10.018_bib113","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0161-6420(13)31339-6","article-title":"Improved visual results after surgical repair of cytomegalovirus-related retinal detachments","volume":"101","author":"Lim","year":"1994","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2010.10.018_bib114","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0002-9394(03)00724-4","article-title":"Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis","volume":"136","author":"Tanna","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2010.10.018_bib115","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/bjo.2009.157727","article-title":"The epidemiology of rhegmatogenous retinal detachment: geographical variation and clinical associations","volume":"94","author":"Mitry","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2010.10.018_bib116","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2004.10.049","article-title":"Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy","volume":"112","author":"Jabs","year":"2005","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib117","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/infdis\/172.3.613","article-title":"Antiviral effects of foscarnet and ganciclovir therapy on human immunodeficiency virus p24 antigen in patients with AIDS and cytomegalovirus retinitis","volume":"172","year":"1995","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib118","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ophtha.2009.06.016","article-title":"Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS","volume":"117","author":"Jabs","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2010.10.018_bib119","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1034\/j.1600-065X.2000.17710.x","article-title":"The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS","volume":"177","author":"O'Brien","year":"2000","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.ajo.2010.10.018_bib120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ng1369","article-title":"Human genes that limit AIDS","volume":"36","author":"O'Brien","year":"2004","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib121","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/QAI.0b013e31816fdc5f","article-title":"Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival","volume":"48","author":"Hendrickson","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib122","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1086\/654814","article-title":"Effect of host genetics on cytomegalovirus retinitis occurrence in patients with AIDS","volume":"202","author":"Sezgin","year":"2010","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.ajo.2010.10.018_bib123","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.4049\/jimmunol.170.11.5578","article-title":"Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production","volume":"170","author":"Gasche","year":"2003","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.ajo.2010.10.018_bib124","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1002\/eji.200837718","article-title":"Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1","volume":"38","author":"Gruber","year":"2008","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.ajo.2010.10.018_bib125","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.ajo.2010.10.018_bib126","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","article-title":"Resolution of a chronic viral infection after interleukin-10 receptor blockade","volume":"203","author":"Ejrnaes","year":"2006","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib127","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9394(01)01322-8","article-title":"Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"133","author":"Jabs","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib128","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajo.2007.09.040","article-title":"Characteristics of untreated AIDS-related cytomegalovirus retinitis","volume":"145","author":"Holland","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib129","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archopht.121.4.466","article-title":"Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome","volume":"121","author":"Kempen","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2010.10.018_bib130","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1371\/journal.pmed.0040334","article-title":"Cytomegalovirus retinitis: The neglected disease of the AIDS pandemic","volume":"4","author":"Heiden","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajo.2010.10.018_bib131","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1076\/ocii.7.3.173.4002","article-title":"The epidemiology of CMV retinitis in Africa","volume":"7","author":"Kestelyn","year":"1999","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib132","first-page":"14","article-title":"Les atteintes oculaires au cours de l'infection par le VIH au CHU de Casablanca","volume":"93","author":"El Mansouri","year":"2000","journal-title":"Bull Soc Pathol Expt"},{"issue":"4","key":"10.1016\/j.ajo.2010.10.018_bib133","first-page":"327","article-title":"Ophthalmic manifestations of AIDS in Armed Forces General Teaching Hospital, Addis Ababa","volume":"45","author":"Giorgis","year":"2007","journal-title":"Ethiop Med J"},{"key":"10.1016\/j.ajo.2010.10.018_bib134","first-page":"7","article-title":"Complications oculaires de l'infection a VIH-SIDA en milieu Camerounais: Y a-t-il une corr\u00e9lation avec le taux de CD4?","volume":"305","author":"Ebana Mvogo","year":"2007","journal-title":"Bull Soc Belge Ophtalmol"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/1117-1936.180918","article-title":"HIV\/AIDS in ophthalmic patients: The Guiness Eye Centre Onitsha experience","volume":"15","author":"Nwosu","year":"2008","journal-title":"Niger Postgrad Med J"},{"issue":"3","key":"10.1016\/j.ajo.2010.10.018_bib136","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11904-008-0019-z","article-title":"Ocular complications of HIV infection in Sub-Saharan Africa","volume":"5","author":"Nkomazand","year":"2008","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"10","key":"10.1016\/j.ajo.2010.10.018_bib137","first-page":"1042","article-title":"R\u00e9tinites \u00e0 cytom\u00e9galovirus et complications oculaires du SIDA au Togo","volume":"22","author":"Balo","year":"1999","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib138","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/QAI.0b013e3181c313f0","article-title":"The prevalence and causes of visual loss among HIV-infected individuals in Uganda","volume":"53","author":"Otitti-Sengeri","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.ajo.2010.10.018_bib139","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9394(99)00415-8","article-title":"Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center","volume":"129","author":"Biswas","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2010.10.018_bib140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.iae.0000249575.38830.45","article-title":"Blindness and low vision in a tertiary ophthalmologic center in Thailand: The importance of cytomegalovirus retinitis","volume":"27","author":"Pathanapitoon","year":"2007","journal-title":"Retina"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939410008172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939410008172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:02:00Z","timestamp":1757595720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939410008172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":140,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0002939410008172"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2010.10.018","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus Retinitis and the Acquired Immunodeficiency Syndrome\u2014Bench to Bedside: LXVII Edward Jackson Memorial Lecture","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2010.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}